RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy.

Sci Rep · 2019 · PMC6423142 · PMID 30886310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This capability is highly significant when designing and optimizing therapeutic protocols in the process of drug development.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.